Missed diagnostic testing has negative impact on lung cancer treatment
the ONA take:
A team of researchers from the Baptist Cancer Center and the University of Memphis, Tennessee, sought to identify the impact of factors associated with care delivery on prognosis for patients with lung cancer.
Their results show that only 1 in 10 patients with lung cancer underwent the recommended combination of diagnostic tests before surgery. In addition, patients waited 1.5 to 6 months to undergo surgery after suspicions of lung cancer are made via radiography.
Recommendations suggest three staging tests before surgery in patients for suspected lung cancer: computed tomography (CT), positron emission tomography (PET), and a biopsy.
According to the study results, 88% of patients did not undergo biopsy, no imaging test was obtained in 22% of patients, and no diagnostic procedure was done before surgery in 27% of patients.
The researchers conclude that delays in final treatment and missed diagnostic tests can hinder outcomes for patients with lung cancer.
Their results highlight the importance of engaging patients in their care from early on to determine the best tests that will lead to an optimal treatment course for that patient.
A team sought to identify the impact of factors associated with care delivery on prognosis for patients with lung cancer.
Sign Up for Free e-newsletters
- Education May Better Equip Nurses to Hold End-of-Life Conversations in Advanced Cancer
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Accurate Understanding of Capacity May Improve Workflow, Efficiency in Infusion Suite
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|